To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia
Clinical trial NCT05218642 · COMPLETED
Trial details
- NCT number
- NCT05218642
- Sponsor
- Suzhou Kintor Pharmaceutical Inc,
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-31
- Primary completion
- 2023-02-13
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.